Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer

Annals of Oncology

Volumn 18, Issue 9, 2007, Pages 1513-1517

  Coutant, C ^a   Barranger, E ^a   Cortez, A ^a   Dabit, D ^a   Uzan, S ^a   Bernaudin, J F ^a   Daraï, Emile ^a  

^a HÔPITAL TENON   (France)

Author keywords

Cervical cancer; Human papillomavirus; Polymerase chain reaction; Sentinel lymph node

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SENTINEL LYMPH NODE; UTERINE CERVIX CANCER; WART VIRUS;

EID: 34548432684     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm192     Document Type: Article

References (30)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36.
2. Bosch FX, de Sanjose S. Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003: 3-13.
3. Fuchs PG, Girardi F, Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: A diagnostic marker for early metastases? Int J Cancer 1989; 43: 41-44.
4. Hopkins MP, Morley GW. Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival. Am J Obstet Gynecol 1991; 164: 1520-1529.
5. Stehman FB, Bundy BN, DiSaia PJ et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991; 67: 2776-2785.
6. van Bommel PF, van den Brule AJ, Helmerhorst TJ et al. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer. Gynecol Oncoll 1993; 48: 333-337.
7. Plante M, Renaud MC, Tetu B et al. Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 2003; 91: 494-503.
8. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1: 149-153.
9. Barranger E, Grahek D, Cortez A et al. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer 2003; 97: 3003-3009.
10. Martinez-Palones JM, Gil-Moreno A, Perez-Benavente MA et al. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol 2004; 92: 845-850.
11. Benedet JL, Bender H, Jones H 3rd et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancer. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70: 209-262.
12. Roca I, Caresia AP, Gil-Moreno A et al. Usefulness of sentinel lymph node detection in early stages of cervical cancer. Eur J Nucl Med Mol Imaging 2005; 32: 1210-1216.
13. Kraft O, Sevcik L, Klat J, Koliba P, Curik R, Kriozva H. Detection of sentinel lymph nodes in cervical cancer. A comparison at two protocols. Nucl Med Rev Cent East Eur 2006; 9: 65-68.
14. Resnick RM, Comelissen MT, Wright DK et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477-1484.
15. Baay MF, Quint WG, Koudstaal J et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996; 34: 745-747.
16. Hemadi Z, Szarka K, Sapy T et al. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: A long term follow up. Bjog 2003; 110: 205-209.
17. Chan PK, Yu MM, Cheung TH et al. Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma. J Clin Virol 2005; 33: 201-205.
18. Baay MF, Koudstaal J, Hollema H et al. Detection of HPV-16 DNA by PCR in histologically cancer free lymph nodes from patients with cervical cancer. J Clin Pathol 1997; 50: 960-961.
19. Barranger E, Coutant C, Cortez A et al. Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease. Ann Oncol 2005; 16: 1237-1242.
20. Lukaszuk K, Liss J, Wozniak I et al. HPV and histological status of pelvic lymph node metastases in cervical cancer: A prospective study. J Clin Pathol 2004; 57: 472-476.
21. Fule T, Csapo Z, Mathe M et al. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol Oncol 2006; 100: 570-578.
22. Sapy T, Hernadi Z, Konya J, Lukacsko L. Poor clinical outcome in early stage cervical cancer with human papillomavirus-18 positive lymph nodes. Eur J Obstet Gynecol Reprod Biol 2000; 90: 93-95.
23. Pilch H, Gunzel S, Schaffer U et al. The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer 2001; 11: 39-48.
24. Burnett AF, Barnes WA, Johnson JC et al. Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer. Gyneool Oncol 1992; 47: 343-347.
25. Kobayashi Y, Yoshinouchi M, Tianqi G et al. Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patents with histologically negative lymph nodes. Clin Cancer Res 1998; 4: 979-983.
26. Hording U, Ravn V, Knudsen J, Visfeldt J. The use of polymerase chain reaction to detect metastatic cancer cells within lymph nodes in stage I cervical carcinoma. Int J Gynecol Pathol 1995; 14: 339-343.
27. Unger ER, Vernon SD, Thorns WW et al. Human papillomavirus and disease-free survival in FIGO stage in cervical cancer. J Infect Dis 1995; 172: 1184-1190.
28. Barnes W, Woodworth G, Waggoner S et al. Rapid dysplastic transformation of human genital cells by human papillomavirus type 18. Gynecol Oncol 1990; 38: 343-346.
29. Beyer-Finkler E, Girardi F, Sillem M, Pfister H. Human papillomavirus DNA in genital cancers, metastases, and lymph nodes. Intervirology 1995; 38: 173-180.
30. Levenback C, Coleman RL, Burke TW et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncoll 2002; 20: 688-693.